EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. AHA2021
Vložit
- čas přidán 4. 12. 2021
- EMPULSE TRIAL. EMPAGLIFLOZIN in patients with acute decompensated heart failure. EMPAGLIFLOZIN is one of the SGLT2 inhibitors.
SGLT2 inhibitors are the new drugs which have been approved for heart failure with reduced ejection fraction (HFrEF). After the landmark EMPA-REG_OUTCOME, DECLARE TIMI 58, EMPEROR REDUCED and DAPA HF trials, empagliflozin and dapagliflozin have found a place in the management of HFrEF or heart failure. Lets discover what makes them special drugs in heart failure.
#heart
#cad
#heartfailure #aha
#cardioed
#cardio
#cardiologist #cardiologia #cardiologie #cardiovascular
Here are some other discussions on SGLT2 inhibitors.
SGLT2 inhibitors in heart failure.
• SGLT-2 inhibitors in H...
Canagliflozin in heart failure.
• CHIEF HF Trial. CANAGL...
EMPEROR PRESERVED TRIAL
• EMPEROR PRESERVED tria...
Cardio Ed Podcast is available on Spotify, Apple Podcast, Google Podcast, Stitcher, Amazon Music & all popular podcast platforms. Here are the links.
Apple
podcasts.apple.com/us/podcast...
Google Podcast
podcasts.google.com/feed/aHR0...
Spotify:
open.spotify.com/show/3SLQ2g4...
Amazon Music
music.amazon.in/podcasts/4215...
Please sir add more trials to your channel as I m having DNB exam in june22 and this channel is very useful to me and my friends
Sorry, i did not see the comment. I hope you do well in your exams. Going to make more videos soon.
Very nice Chanel sir very useful for DNB and dm going students
DNB means?
Excellent
How to get this medication sir? My father was diagnosed diastolic heart failure.
buenas tardes, me podria compartir el articulo por favor....
I have the article. Let me know if you need it.
@@CardioEd hello, can you send me the article??
Pls give me your email address